Form 4: Intuitive Surgical Director's Performance Stock Units Vesting

Sentiment:

Executive Compensation Update


Intuitive Surgical Director Gary S. Guthart reported the acquisition of performance stock units following the achievement of performance metrics.

Summary

  • Gary S. Guthart, a Director of Intuitive Surgical Inc. (ISRG), reported the acquisition of Performance Stock Units (PSUs) on January 28, 2026.
  • A total of 8,267 PSUs, initially granted on February 26, 2024, were reported as acquired. These units are scheduled to vest on February 26, 2027.
  • An additional 17,556 PSUs, initially granted on February 28, 2023, were also reported as acquired. These units are scheduled to vest on February 28, 2026.
  • The Compensation Committee of Intuitive Surgical Inc. determined that the performance criteria for both sets of PSUs have been successfully achieved.
  • Vesting for all reported PSUs is contingent upon Mr. Guthart's continuous service to the Issuer through each respective vesting date.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting the achievement of performance targets and the continued alignment of executive incentives with shareholder value, though it is a routine compensation disclosure.

Positives

  • Performance criteria for both PSU grants were achieved, indicating strong company performance against set targets.
  • The grants align executive incentives with long-term shareholder value, promoting sustained growth and strategic execution.

Risks

  • Vesting of the PSUs is subject to Mr. Guthart's continuous service to the Issuer through the specified vesting dates, meaning the units could be forfeited if his service terminates prematurely.

Future Outlook

The 17,556 PSUs are expected to vest on February 28, 2026, and the 8,267 PSUs are expected to vest on February 26, 2027, both contingent on Mr. Guthart's continuous service to the company.

Industry Context

StockSavvy.ai notes that the grant and vesting of performance stock units are a common form of executive compensation in the medical device and technology sectors, designed to align executive incentives with company performance and long-term shareholder interests.

Comparison to Industry Standards

  • StockSavvy.ai observes that performance-based equity awards, such as PSUs, are a standard component of executive compensation packages across leading companies in the healthcare technology sector, including peers like Johnson & Johnson (JNJ) MedTech, Medtronic (MDT), and Stryker (SYK).
  • The structure, tying vesting to both performance metrics and continuous service, is consistent with best practices aimed at retaining key talent and driving strategic objectives within the industry.

Stakeholder Impact

  • Shareholders: Potential future dilution upon the vesting of PSUs, but also indicates management's incentives are aligned with company performance and long-term value creation.
  • Employees: No direct impact mentioned, but the achievement of performance metrics could reflect overall company success, potentially benefiting the broader employee base.

Next Steps

  • Vesting of 17,556 PSUs on February 28, 2026, subject to continuous service.
  • Vesting of 8,267 PSUs on February 26, 2027, subject to continuous service.

Key Dates

DateDescription
02/28/2023Initial grant date for 17,556 Performance Stock Units.
02/26/2024Initial grant date for 8,267 Performance Stock Units.
01/28/2026Date performance criteria were achieved for both PSU grants, leading to their reporting as acquired.
01/30/2026Filing date of the Form 4 statement.
02/28/2026Vesting date for 17,556 Performance Stock Units, subject to continuous service.
02/26/2027Vesting date for 8,267 Performance Stock Units, subject to continuous service.

Keywords

Intuitive Surgical, ISRG, Performance Stock Units, PSUs, Executive Compensation, Insider Trading, Form 4, Director Compensation, Equity Awards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.